• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC - GALWAY SYNERGY II EVEROLIMUS-ELUTING PLATINUM CHROMIUM CORONARY STENT SYSTEM; BIODEGRADABLE POLYMER DRUG ELUTING CORONARY STENT SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC - GALWAY SYNERGY II EVEROLIMUS-ELUTING PLATINUM CHROMIUM CORONARY STENT SYSTEM; BIODEGRADABLE POLYMER DRUG ELUTING CORONARY STENT SYSTEM Back to Search Results
Model Number H7493926038350
Device Problem Occlusion Within Device (1423)
Patient Problems Chest Pain (1776); Thrombosis (2100)
Event Date 01/29/2018
Event Type  Injury  
Manufacturer Narrative
Device is a combination product.It is indicated that the device will not be returned for evaluation.If there is any further relevant information obtained, a supplemental medwatch will be filed.(b)(4).
 
Event Description
Same case as mdr id 2134265-2018-00166.It was reported that thrombosis occurred.In (b)(6) 2017, the patient presented for percutaneous coronary intervention (pci).The target lesion was located in the left circumflex artery.A 182cm choice¿ guide wire was advanced to the lesion; however, the wire became stuck behind the stent strut.The wire was completely coated in polymer but the tip looked like a "spring coil".It was impossible to remove the detach fragment and, so it remained in the patient.The physician took ownership, and said it was not a product failure, it was just based upon where he had put it.The physician ended up stenting and tacking it up against the wall and the procedure was completed.The patient got a lot of comorbidities and had an ischemic stroke with an unknown origin.However, the patient's condition was very fair with no further patient complications reported.In (b)(6) 2018, the patient came back with either thrombosis or restenosis in the 3.50 x 38 synergy ii drug-eluting stent that covered the detach guide wire fragment.The vessel is down at this point.This time, the patient had multi-vessel disease.The patient was doing fine and stable, and was scheduled for coronary artery bypass grafting (cabg).
 
Manufacturer Narrative
Describe event or problem and patient codes updated.Outcomes attrib.To ae corrected from other to hospitalization and required intervention.(b)(4).
 
Event Description
It was further reported that in (b)(6) 2018 the patient presented in the emergency department with chest pain which led to the discovery of in-stent thrombosis.The patient needed coronary artery bypass grafting which was performed in another hospital.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SYNERGY II EVEROLIMUS-ELUTING PLATINUM CHROMIUM CORONARY STENT SYSTEM
Type of Device
BIODEGRADABLE POLYMER DRUG ELUTING CORONARY STENT SYSTEM
Manufacturer (Section D)
BOSTON SCIENTIFIC - GALWAY
MDR Report Key7287390
MDR Text Key100645304
Report Number2134265-2018-01124
Device Sequence Number1
Product Code NIQ
UDI-Device Identifier08714729840428
UDI-Public08714729840428
Combination Product (y/n)N
PMA/PMN Number
P150003
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Type of Report Initial,Followup
Report Date 01/29/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date02/20/2018
Device Model NumberH7493926038350
Device Catalogue Number39260-3835
Device Lot Number0020340144
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 01/29/2018
Initial Date FDA Received02/21/2018
Supplement Dates Manufacturer Received02/22/2018
Supplement Dates FDA Received03/20/2018
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Other; Required Intervention;
Patient Age67 YR
-
-